New Journey Health Technology Group Co.,LTD (SHE:002219)
China · Delayed Price · Currency is CNY 2.390
+0.050 (2.14%)
May 8, 2026, 3:04 PM CST
SHE:002219 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 2,977 | 3,053 | 3,789 | 3,903 | 3,153 | 3,007 |
Other Revenue | - | - | 9.78 | 11.19 | 8.13 | 8.79 |
| 2,977 | 3,053 | 3,799 | 3,914 | 3,161 | 3,016 | |
Revenue Growth (YoY) | -18.27% | -19.64% | -2.94% | 23.83% | 4.80% | 7.49% |
Cost of Revenue | 2,100 | 2,173 | 2,623 | 2,742 | 2,169 | 2,209 |
Gross Profit | 876.64 | 879.35 | 1,176 | 1,173 | 992.42 | 807.44 |
Selling, General & Admin | 550.14 | 576.17 | 805.16 | 874.74 | 690.55 | 717.15 |
Research & Development | 14.45 | 13.35 | 9.86 | 27.71 | 0.24 | 0.44 |
Other Operating Expenses | 14.93 | 14.24 | 22.44 | 21.17 | 17.92 | 20.38 |
Operating Expenses | 579.52 | 603.77 | 869.21 | 995.87 | 762.51 | 843 |
Operating Income | 297.13 | 275.58 | 307.21 | 176.87 | 229.91 | -35.56 |
Interest Expense | -0.81 | - | -135.03 | -128.48 | -142.62 | -230.03 |
Interest & Investment Income | - | - | 13.79 | 28.97 | 59.64 | 26.63 |
Currency Exchange Gain (Loss) | - | - | - | - | 0 | - |
Other Non Operating Income (Expenses) | -217.95 | -190.56 | -32.81 | -68.39 | 40.43 | -17.08 |
EBT Excluding Unusual Items | 78.36 | 85.02 | 153.16 | 8.97 | 187.36 | -256.03 |
Impairment of Goodwill | - | - | - | - | - | -102.59 |
Gain (Loss) on Sale of Investments | -3.42 | -3.41 | 0.01 | - | - | - |
Gain (Loss) on Sale of Assets | 3.33 | 0.23 | -0.07 | -0.19 | -0.17 | -0.67 |
Asset Writedown | -3.85 | -3.88 | -1.19 | -3.38 | -1.67 | -17.12 |
Legal Settlements | - | - | - | - | -0.39 | -0.3 |
Other Unusual Items | - | - | 2.33 | 5.69 | 2.47 | 14.33 |
Pretax Income | 74.42 | 77.96 | 154.23 | 11.09 | 187.59 | -362.39 |
Income Tax Expense | 45.1 | 44.48 | 33.9 | -28.77 | 22.71 | 4.91 |
Earnings From Continuing Operations | 29.32 | 33.48 | 120.33 | 39.86 | 164.89 | -367.3 |
Minority Interest in Earnings | -3.56 | -2.54 | -5.56 | -10.89 | -8.77 | -4.13 |
Net Income | 25.76 | 30.94 | 114.77 | 28.97 | 156.12 | -371.43 |
Net Income to Common | 25.76 | 30.94 | 114.77 | 28.97 | 156.12 | -371.43 |
Net Income Growth | -77.03% | -73.04% | 296.13% | -81.44% | - | - |
Shares Outstanding (Basic) | 3,301 | 3,292 | 3,288 | 3,255 | 3,266 | 1,866 |
Shares Outstanding (Diluted) | 3,301 | 3,292 | 3,288 | 3,255 | 3,266 | 1,866 |
Shares Change (YoY) | 0.64% | 0.10% | 1.02% | -0.33% | 75.08% | -0.02% |
EPS (Basic) | 0.01 | 0.01 | 0.03 | 0.01 | 0.05 | -0.20 |
EPS (Diluted) | 0.01 | 0.01 | 0.03 | 0.01 | 0.05 | -0.20 |
EPS Growth | -77.17% | -73.07% | 292.13% | -81.38% | - | - |
Free Cash Flow | 120.73 | 36.78 | 131.06 | 111.25 | 46.47 | 78.56 |
Free Cash Flow Per Share | 0.04 | 0.01 | 0.04 | 0.03 | 0.01 | 0.04 |
Gross Margin | 29.45% | 28.80% | 30.97% | 29.96% | 31.40% | 26.77% |
Operating Margin | 9.98% | 9.03% | 8.09% | 4.52% | 7.27% | -1.18% |
Profit Margin | 0.86% | 1.01% | 3.02% | 0.74% | 4.94% | -12.31% |
Free Cash Flow Margin | 4.06% | 1.21% | 3.45% | 2.84% | 1.47% | 2.60% |
EBITDA | 463.93 | 440.98 | 466.94 | 384.69 | 385.85 | 127.28 |
EBITDA Margin | 15.59% | 14.45% | 12.29% | 9.83% | 12.21% | 4.22% |
D&A For EBITDA | 166.81 | 165.39 | 159.73 | 207.82 | 155.94 | 162.84 |
EBIT | 297.13 | 275.58 | 307.21 | 176.87 | 229.91 | -35.56 |
EBIT Margin | 9.98% | 9.03% | 8.09% | 4.52% | 7.27% | -1.18% |
Effective Tax Rate | 60.60% | 57.06% | 21.98% | - | 12.10% | - |
Revenue as Reported | - | - | 3,799 | 3,914 | 3,161 | 3,016 |
Advertising Expenses | - | - | 265.25 | 187.86 | 71.92 | 58.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.